be particularly problematic in the case of benzimidazoles
and indazoles. Mixtures of N-1 and N-2/3 protected regioi-
somers are often formed, which can display different
reactivities under cross-coupling conditions.15-17 A general
method for the amination of unprotected haloheterocycles
would thus offer a valuable tool for the synthesis of these
important molecules.
couplings with both aromatic and aliphatic secondary amines
(Scheme 1). Moreover, a range of functional groups are well
Scheme 1
.
Cross-of Coupling Bromo-indazoles with Secondary
Aminesa
The development, by our group, of new phosphine ligands,
along with Pd-precatalysts for the rapid generation of
monoligated Pd(0) species, has resulted in robust and general
catalyst systems for C-N cross-coupling reactions.18,19 Such
systems should be ideal for addressing the challenges of
selectivity and functional group tolerance posed by these
benzofused heterocyclic halides.
We recently reported an efficient protocol for the Pd-
catalyzed C-N cross-coupling of bromo and chloro 7-aza-
indoles, using our Pd-precatalyst systems (Figure 2) in
a Reaction conditions: bromoindazole (0.5 mmol), amine (0.6 mmol),
L1 (1 mol %), P1 (1 mol %), LiHMDS (1.2 mmol, 1 M in THF). Isolated
yields are for an average of at least two runs. b 2 M solution of HNMe2 in
THF. c HCl salt of amine. d 3.4 equiv ofLiHMDS (1.7 mmol). e L2 (1 mol
%), P2 (1 mol %).
Figure 2. Ligands and precatalysts used herein.
combination with LiHMDS.20 This method would be of even
greater appeal if it were applicable to a wider range of
heterocyclic halides, allowing the synthesis of a variety of
amino-heterocycles.
We were pleased to discover that under the same reaction
conditions as developed for azaindoles, using a RuPhos based
catalyst system (P1) and LiHMDS in THF as the base, 4-,
5- and 6-bromo-indazoles underwent efficient C-N cross-
tolerated. In particular, pharmacologically relevant and
functionally complex amines, such as the 4-(4-chlorophenyl)-
4-hydroxypiperidine from haloperidol21 (1i), underwent this
transformation in good yields. Notably, in cases where a
bromoheterocycle was combined with an amine containing
an aryl chloride, no reaction of the chloride was observed
(1b, 1f, 1i).
We next examined the coupling of 4-, 5-, and 6-bromoin-
dazoles with primary amines, using the BrettPhos precatalyst
(P3, Figure 2), which is often the preferred ligand for cross-
coupling reactions of this type.19 Using this system both
aliphatic and heteroaromatic amines could be incorporated
in high yields (Scheme 2).
Whereas a wide variety of amines could be employed,
electron-deficient secondary anilines, such as 4-N-methy-
laminobenzonitrile and N-methylaminopyridines, proved to
be uniquely challenging coupling partners. Only trace
amounts of the desired products were detected after extended
reaction times, with increased catalyst loading, or with
various bases. We hypothesized that the reductive elimination
of these substrates might be slow as a result of their reduced
nucleophilicity, and thus we reasoned that a more bulky
phosphine ligand might be more effective in facilitating this
step.22 Indeed, we found that a t-BuXPhos-derived catalyst
(10) Anderson, K. W.; Tundel, R. E.; Ikawa, T.; Altman, R. A.;
Buchwald, S. L. Angew. Chem., Int. Ed. 2006, 45, 6523–6527
.
(11) Charles, M. D.; Schultz, P.; Buchwald, S. L. Org. Lett. 2005, 7,
3965–3968
.
(12) Scribner, A.; Moore, J. A.; Ouvry, G.; Fisher, M.; Wyvratt, M.;
Leavitt, P.; Liberator, P.; Gurnett, A.; Brown, C.; Mathew, J.; Thompson,
D.; Schmatz, D.; Biftu, T. Bioorg. Med. Chem. Lett. 2009, 19, 1517–1521
(13) Brown, D. A.; Mishra, M.; Zhang, S.; Biswas, S.; Parrington, I.;
.
Antonio, T.; Reith, M. E. A.; Dutta, A. K. Bioorg. Med. Chem. 2009, 17,
3923–3933
.
(14) Fucini, R. V.; Hanan, E. J.; Romanowski, M. J.; Elling, R. A.; Lew,
W.; Barr, K. J.; Zhu, J.; Yoburn, J. C.; Liu, Y.; Fahr, B. T.; Fan, J. F.; Lu,
Y.; Pham, P.; Choong, I. C.; VanderPorten, E. C.; Bui, M.; Purkey, H. E.;
Evanchik, M. J.; Yang, W. J. Bioorg. Med. Chem. Lett. 2008, 18, 5648–
5652
.
(15) Gontcharov, A. V.; Khafizova, G.; Potoski, J. R.; Huryn, D. M.
Processes for preparing gonadotropin releasing hormone receptor antago-
nists, Patent US 2005/0282820 A1, 2005
(16) Lopez-Rodriguez, M. L.; Benhamu, B.; Ayala, D.; Rominguera,
.
J. L.; Murcia, M.; Ramos, J. A.; Viso, A. Tetrahedron 2000, 56, 3245–
3253
.
(17) Slade, D. J.; Pelz, N. F.; Bodnar, W.; Lampe, J. W.; Watson, P. S.
J. Org. Chem. 2009, 74, 6331–6334
(18) Biscoe, M. R.; Fors, B. P.; Buchwald, S. L. J. Am. Chem. Soc.
2008, 130, 6686–6687
(19) Fors, B. P.; Watson, D. A.; Biscoe, M. R.; Buchwald, S. L. J. Am.
Chem. Soc. 2008, 130, 13552–13554
.
.
.
(21) Vangveravong, S.; McElveen, E.; Taylor, M.; Xu, J. B.; Tu, Z.;
Luedtke, R. R.; Mach, R. H. Bioorg. Med. Chem. 2006, 14, 815–825.
(22) Hartwig, J. F. Inorg. Chem. 2007, 46, 1936–1947.
(20) Henderson, J. L.; McDermott, S. M.; Buchwald, S. L. Org. Lett.
2010, DOI:, 10.1021/ol101928m.
Org. Lett., Vol. 12, No. 20, 2010
4443